Literature DB >> 25730723

Health-related quality of life measurement in oncology: advances and opportunities.

David Cella1, Arthur A Stone2.   

Abstract

The concept of health-related quality of life has a long history in the field of oncology treatment and research. We present a brief history of how the concept has evolved in oncology and the sentinel events in that process. We then focus on advances in measurement science as applied to health-related quality of life measures and argue that a compelling new set of measurement tools is now available, including brief, generic measures with good psychometric qualities (exemplified by the new PROMIS measures and the possibility of a common metric spanning all diseases). The last section of the paper turns to emerging opportunities for these measures, including in clinical trials, healthcare reform, and regulatory deliberations. Our conclusion is that health-related quality of life is more important today than it has ever been, and that the time has come for an even wider adoption of the new measures. PsycINFO Database Record (c) 2015 APA, all rights reserved.

Mesh:

Year:  2015        PMID: 25730723     DOI: 10.1037/a0037821

Source DB:  PubMed          Journal:  Am Psychol        ISSN: 0003-066X


  20 in total

1.  Impact of Interdisciplinary Outpatient Specialty Palliative Care on Survival and Quality of Life in Adults With Advanced Cancer: A Meta-Analysis of Randomized Controlled Trials.

Authors:  Michael Hoerger; Graceanne R Wayser; Gregory Schwing; Ayako Suzuki; Laura M Perry
Journal:  Ann Behav Med       Date:  2019-06-04

2.  Differences in Health-Related Quality of Life and Health Behaviors Among Lesbian, Bisexual, and Heterosexual Women Surviving Cancer from the 2013 to 2018 National Health Interview Survey.

Authors:  Megan L Hutchcraft; Andreas A Teferra; Lauren Montemorano; Joanne G Patterson
Journal:  LGBT Health       Date:  2020-12-16       Impact factor: 4.151

Review 3.  Ambulatory and diary methods can facilitate the measurement of patient-reported outcomes.

Authors:  Stefan Schneider; Arthur A Stone
Journal:  Qual Life Res       Date:  2015-06-23       Impact factor: 4.147

4.  Financial Strain and Physical and Emotional Quality of Life in Breast Cancer.

Authors:  Laura M Perry; Michael Hoerger; Katherine Seibert; James I Gerhart; Sean O'Mahony; Paul R Duberstein
Journal:  J Pain Symptom Manage       Date:  2019-06-01       Impact factor: 3.612

5.  A Validation Study of the Mini-IPIP Five-Factor Personality Scale in Adults With Cancer.

Authors:  Laura M Perry; Michael Hoerger; Lisa A Molix; Paul R Duberstein
Journal:  J Pers Assess       Date:  2019-08-12

6.  Development and psychometric evaluation of the Decisional Engagement Scale (DES-10): A patient-reported psychosocial survey for quality cancer care.

Authors:  Michael Hoerger; Benjamin P Chapman; Supriya G Mohile; Paul R Duberstein
Journal:  Psychol Assess       Date:  2016-09

7.  Cancer survivor perspectives on sharing patient-generated health data with central cancer registries.

Authors:  T G Smith; M E Dunn; K Y Levin; S P Tsakraklides; S A Mitchell; L V van de Poll-Franse; K C Ward; C L Wiggins; X C Wu; M Hurlbert; N K Aaronson
Journal:  Qual Life Res       Date:  2019-08-09       Impact factor: 4.147

8.  Exploring measurement invariance by gender in the profile of mood states depression subscale among cancer survivors.

Authors:  Jihye Kim; Tenbroeck Smith
Journal:  Qual Life Res       Date:  2016-11-11       Impact factor: 4.147

Review 9.  Cancer survivorship monitoring systems for the collection of patient-reported outcomes: a systematic narrative review of international approaches.

Authors:  N Corsini; J Fish; I Ramsey; G Sharplin; I Flight; R Damarell; B Wiggins; C Wilson; D Roder; M Eckert
Journal:  J Cancer Surviv       Date:  2017-04-03       Impact factor: 4.442

10.  Patient-Reported Quality-of-Life Outcome Measures in the Thyroid Cancer Population.

Authors:  Eve M Roth; Carrie C Lubitz; John Shannon Swan; Benjamin C James
Journal:  Thyroid       Date:  2020-05-14       Impact factor: 6.568

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.